There are scant data on the impact of coronavirus disease 2019 (COVID-19) on hospital antibiotic consumption, and no data from outside epicenters. At our nonepicenter hospital, antibiotic days of therapy (DOT) and bed days of care (BDOC) were reduced by 151.5/month and 285/month, respectively, for March to June 2020 compared to 2018-2019 ( P = 0.001 and P < 0.001). DOT per 1,000 BDOC was increased (8.1/month; P = 0.001). COVID-19 will impact antibiotic consumption, stewardship, and resistance in ways that will likely differ temporally and by region.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, Antibiotics, Antimicrobial stewardship,
【저자키워드】 COVID-19, SARS-CoV-2, Antibiotics, Antimicrobial stewardship,